← Back to Discover
Eversept Partners, LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $1,927,640,043
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- UNITED THERAPEUTICS CORP DEL · COM · 91307C102 · shares: $155,867,152
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares: $121,783,649
- ENCOMPASS HEALTH CORP · COM · 29261A100 · shares: $103,800,973
- ENSIGN GROUP INC · COM · 29358P101 · shares: $96,513,264
- VERA THERAPEUTICS INC · CL A · 92337R101 · shares: $94,949,961
- INVESCO QQQ TR · UNIT SER 1 · 46090E103 · shares · PUT: $72,609,040
- CELLDEX THERAPEUTICS INC NEW · COM NEW · 15117B202 · shares: $66,454,865
- SYNDAX PHARMACEUTICALS INC · COM · 87164F105 · shares: $61,168,871
- BROOKDALE SR LIVING INC · COM · 112463104 · shares: $54,649,202
- IONIS PHARMACEUTICALS INC · COM · 462222100 · shares: $52,702,794
Reported holdings
120 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 6,943 shares | $1,300,285 |
| SAVARA INC | COM | 805111101 | — | 204,428 shares | $1,259,276 |
| SURROZEN INC | COM NEW | 86889P208 | — | 47,777 shares | $1,239,813 |
| INOVIO PHARMACEUTICALS INC | COM SHS | 45773H409 | — | 1,035,360 shares | $1,138,896 |
| PLIANT THERAPEUTICS INC | COM | 729139105 | — | 891,425 shares | $1,016,224 |
| CYBIN INC | COM NEW | 23256X407 | — | 146,403 shares | $967,724 |
| ODYSSEY THERAPEUTICS INC | COMMON STOCK | 67613T104 | — | 49,658 shares | $929,101 |
| ENGENE THERAPEUTICS INC | COM | 29286X101 | — | 469,584 shares | $812,380 |
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | — | 190,715 shares | $808,632 |
| LIPOCINE INC NEW | COM NEW | 53630X203 | — | 294,989 shares | $755,172 |
| RELMADA THERAPEUTICS INC | COM | 75955J402 | — | 93,192 shares | $644,889 |
| EHEALTH INC | COM | 28238P109 | — | 404,854 shares | $603,232 |
| ATAIBECKLEY INC | COM SHS | 04650F101 | — | 102,430 shares | $539,806 |
| AKEBIA THREAPEUTICS INC | COM | 00972D105 | — | 427,095 shares | $486,888 |
| SS INNOVATIONS INTERNATIONAL | COM NEW | 05453U203 | — | 110,157 shares | $457,152 |
| ASSEMBLY BIOSCIENCES INC | COM NEW | 045396207 | — | 16,510 shares | $453,695 |
| RETRACTABLE TECHNOLOGIES INC | COM | 76129W105 | — | 580,919 shares | $418,262 |
| SELECTQUOTE INC | COM | 816307300 | — | 319,788 shares | $268,974 |
| GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | — | 8,672 shares | $233,103 |
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | — | 10,000 shares | $184,800 |